SV LIFE Sciences FUND IV Strategic Partners, L. P., 10% Owner at KalVista Pharmaceuticals, Inc. (KALV), sold 427,247 shares at $20.60 ($8.8M) on 2019-02-21, disclosed to the SEC on 2019-02-21.
Open-market sale of $8.8M KALV by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.73 | 508 | $11K | 0.1% |
| 2 | $20.73 | 17,912 | $371K | 4.2% |
| 3 | $20.73 | 17,912 | $371K | 4.2% |
| 4 | $20.02 | 641 | $13K | 0.1% |
| 5 | $20.02 | 22,594 | $452K | 5.2% |
| 6 | $20.02 | 22,594 |
| $452K |
| 5.2% |
| 7 | $20.60 | 4,764 | $98K | 1.1% |
| 8 | $20.60 | 4,764 | $98K | 1.1% |
| 9 | $20.60 | 167,779 | $3.5M | 39.4% |
| 10 | $20.60 | 167,779 | $3.5M | 39.4% |
| Total | $20.55 avg | 427,247 | $8.8M | 100% |
| Filing → |
| OCUL | SELL | 2015-06-11 | $16.4M | — | Filing → |
| OPHT | SELL | 2014-06-05 | $55.8M | — | Filing → |
| TRXC | BUY | 2014-04-23 | $3.0M | — | Filing → |